1. GLOBAL MARKET PERSPECTIVE

1.1 Introduction
1.2 Product Outline
1.2.1 Biomarkers
1.2.2 Biomarkers and Surrogate Endpoints
1.2.3 Nanobiotechnology's Biomarker Discovery for Personalized medicine
1.2.4 Biomarkers Research and Approval
1.2.5 Biomarker Discovery Technologies
1.2.5.1 Genomics
1.2.5.2 Proteomics
1.2.5.3 Bioinformatics
1.2.5.4 Molecular Imaging Technologies
1.2.5.5 Molecular Imaging Biomarkers for Cancer
1.2.5.6 Metabolomics
1.2.5.7 Nuclear Magnetic Resonance
1.2.6 Challenges in Discovering Biomarkers

1.3 Application Analysis
1.3.1 Biomarkers in Diagnostics
1.3.2 Biomarkers in Drug Discovery and Drug Development
1.3.2.1 Basic Drug Development Research
1.3.2.2 Later Drug Development
1.3.2.3 Clinical Trials
1.3.2.4 Future Uses
1.3.2.5 Concerns
1.3.3 Biomarkers in Ecotoxicology
1.3.4 Biomarkers in Exposure
1.3.5 Biomarkers in Therapeutics
1.3.5.1 Cardiology
Cardiac Biomarkers Used
Cardiac Biomarkers and Timing of Use
1.3.5.2 Oncology
1.3.5.3 Neurology
1.3.6 Biomarkers in Disease
Diabetes
Use of SELDI in Discovering Infectious Disease Biomarkers
1.3.7 MicroRNAs (miRNAs)
Functions of microRNAs
MicroRNAs as Biomarkers
MicroRNAs in Diseases
Malignancies
Multiple Sclerosis (MS)
Transplantation

1.4 Recent Biomarker Case Studies
1.4.1 CASE STUDY I – AAPS Workshop on Translational Biomarkers for Accelerating Drug Development
Purpose of the Study
Process of the Study
Regulatory Biomarkers
Results Ascertained/Problems Faced
1.4.2 CASE STUDY II – AMGEN
Purpose of the Study
Process Involved
Classes of Biomarkers
Selected Validated Biomarkers
Emerging Biomarkers: An Overview
1.4.3 CASE STUDY III – The Promise of Imaging Biomarkers-Thomson Reuters
Purpose of the Study
Introduction
Process
An Overview of Imaging Technologies in Use
R&D Applications of Imaging Biomarkers
Clinical Applications of Imaging Biomarkers
Future Vistas
Hurdles to be Crossed
Imaging Biomarkers' Application
What Lies in Store
1.4.4 CASE STUDY IV – Sperling and Johnson Alzheimer's Research & Therapy 2010
Purpose of the Study
Introduction
Process
Conclusions
1.4.5 CASE STUDY V – Shimadzu Scientific Instruments
Purpose of the Study
Introduction
Instance-1
Instance-2
Instance-3

1.5 Current Market Scenario
Phosphoproteomics Used in Identifying Potential Cancer Drug Development Biomarkers
Spinal Fluid Biomarkers Assist in Classifying Alzheimer's Disease Patients
Biomarker for Oral Cancer Discovered
Can Brain Injuries be detected by a Simple Blood Test'
Postmenopausal Cardiovascular Disease Biomarkers Discovered
Quantifying Urinary Biomarkers of Kidney Damage Using Multiplex Panels
Advancing Cancer Drug Development Using Biomarkers
Developing and Validating Imaging Biomarkers in Preclinical Drug Development
Ocular Disease Identifying Biomarkers in Ocular Fluid
Genomics-Based Gene Expression Signature Biomarkers in Oncology and Toxicology Enable in Drug Discovery and Translational Medicine
Role of Inflammation in Vascular Disease Shown by Biomarker Ratifies Ethnic Group Disease Progressions (USA)
Kidney Damage Biomarkers to Help in Speeding Drug Development
Parkinson's Disease and Need for Biomarkers
Goal of Effective and Personalized Cancer Medicine to be Realized by Biomarkers
Acute Coronary Syndrome and Diagnostic Biomarkers
Pharmacodynamic Biomarkers for Molecular Cancer Therapeutics
A Metabonomic Approach to Identify Human Urinary Phenylacetylglutamine as an Innovative Marker of Interstitial Cystitis
Serum Biomarker for Autistic Spectrum Disorder
Prognostic Biomarker in Human Bladder Cancer
Breast Cancer Biomarker Discovery Using New Method

1.6 Major Global Players
1.7 Key Business Trends
VisEn Medical Acquired by PerkinElmer
Hologic Acquires Sentinelle Medical
Thermo Fisher Scientific in Collaboration to Set Up New Biomarker Research Center in Tokyo
Axela Takes Over Xceed Molecular
Merck KGaA Acquires Millipore Corporation
Eli Lilly Acquires Alnara Pharmaceuticals
Fermentas International Inc Acquired by Thermo Fisher
Astellas Acquires OSI Pharmaceuticals
Critical Path´s Protein Biomarker Panel for Drug Toxicity Studies Approved by Japanese Regulators
Roche Diagnostics, American College of Cardiology in Collaboration
Affymetrix Introduces Axiom™ Genome-Wide ASI Array
Abbott Acquires Facet Biotech
Biocartis and Royal Philips Electronics Form Agreement
Predictive Biosciences Acquires OncoDiagnostic Laboratory
QIAGEN N.V Completes Acquisition of SABiosciences
HandyLab, Inc Taken Over by Becton, Dickinson and Co
DxS Ltd Acquired by QIAGEN N.V
Thermo Fisher Acquires B-R-A-H-M-S
Bristol-Myers Squibb Acquires Medarex, Inc.
Agilent Completes Acquisition of Varian
PerkinElmer Completes Acquisition of Analytica of Branford, Inc
Tepnel Life Sciences Acquired by Gen-Probe
Roche Acquires Genentech
Affymetrix Acquires Panomics
Eli Lilly Acquires ImClone Systems
Affymetrix in Collaboration with Medical Prognosis Institute Develop Cancer
Treatment Products
September 2008
Bayer HealthCare AG Takes Over DIREVO Biotech AG
Charles River Takes Over MIR Preclinical Services
Lilly Completes SGX Acquisition
QIAGEN Takes Over Corbett Life Science
Thermo Fisher Scientific Completes Acquisition of Open Biosystems
GlaxoSmithKline Takes Over Sirtris Pharmaceuticals, Inc
BD Acquires Cytopeia
EUSA Pharma Acquires Cytogen Corporation
American Biological Technologies Acquired by Fujirebio Diagnostics
Celera, Merck in License Agreement for Cancer Targets
Abraxis BioScience Takes Over Shimoda Biotech and Platco Technologies
BG Medicine, ACS Biomarker B.V in an Agreement
Affymetrix Takes Over USB Corporation

1.8 Global Market Overview
1.8.1 Market Overview by Biomarker Discovery Technology
1.8.2 Market Overview by Biomarker Therapeutic Area
1.8.3 Biomarker Discovery Technology Market Overview by Global Region
1.8.3.1 Bioinformatics
1.8.3.2 Genomics
1.8.3.3 Molecular Imaging
1.8.3.4 Proteomics
1.8.3.5 Other Biomarker Discovery Technologies
1.8.4 Biomarker Therapeutic Area Market Overview by Global Region
1.8.4.1 Cardiology
1.8.4.2 Neurology
1.8.4.3 Oncology
1.8.4.4 Other Disease Areas

2. REGIONAL MARKET PERSPECTIVE
2.1 Regional Market Overview
2.1.1 The United States
2.1.1.1 Market Overview by Biomarker Technology
2.1.1.2 Market Overview by Biomarker Therapeutic Area
2.1.1.3 Major Market Players
Abbott Laboratories
Affymetrix, Inc
Agilent Technologies
AltheaDx
Amgen
Analytical Biological Services Inc.
Applied NeuroSolutions
Asuragen, Inc
Aureon Biosciences
AVIVA Biosciences Corporation
Banyan Biomarkers Inc.
Beckman Coulter, Inc
Becton, Dickinson and Company
BG Medicine Inc.
Biomarker Pharmaceuticals, Inc.
Bio-Rad Laboratories
Bristol-Myers Squibb Company
Celera Corporation
Charles River Laboratories International, Inc
Clarient, Inc
Eli Lilly and Company
Gene Logic, Inc.
GeneGo
Genentech, Inc
Genomic Health Inc
Geron Corporation
HistoRx, Inc.
Life Technologies
Merck & Co., Inc.
Millennium Pharmaceuticals, Inc.
Millipore Corporation
Monogram Biosciences, Inc.
Myriad Genetics, Inc
OSI Pharmaceuticals
Pacific Biomarkers, Inc
PerkinElmer, Inc.
Pfizer, Inc.
Philips Healthcare
Roche Diagnostics Corporation
Shimadzu Scientific Instruments, Inc.
Siemens Healthcare Diagnostics Inc.
Sigma-Aldrich Corporation
Thermo Fisher Scientific, Inc

2.1.2 Europe
2.1.2.1 Market Overview by European Region
2.1.2.2 Market Overview by Biomarker Technology
2.1.2.3 Market Overview by Biomarker Therapeutic Area
2.1.2.4 Biomarker Technology Market Overview by European Region
Bioinformatics
Genomics
Molecular Imaging
Proteomics
Other Biomarker Discovery Technologies
2.1.2.5 Major Market Players
ACE BioSciences A/S (Denmark)
Affibody AB (Sweden)
Agendia B.V (Netherlands)
Alphalyse A/S (Denmark)
AstraZeneca plc (United Kingdom)
Bayer AG (Germany)
Biacore International AB (Sweden)
Biocartis (Switzerland)
bioMerieux SA (France)
Biosystems International (France)
Boehringer Ingelheim (Germany)
Dako A/S (Denmark)
deCODE Genetics (Iceland)
Epigenomics AG (Germany)
Genedata AG (Switzerland)
GE Healthcare (United Kingdom)
GlaxoSmithKline (United Kingdom)
Novartis AG (Switzerland)
Sanofi-Aventis (France)

2.1.2.6 European Market Overview by Country
Germany
The United Kingdom
France
Italy
Spain
Sweden
Rest of Europe

2.1.3 Asia-Pacific
2.1.3.1 Market Overview by Asia-Pacific Region
2.1.3.2 Market Overview by Biomarker Technology
2.1.3.3 Market Overview by Biomarker Therapeutic Area
2.1.3.4 Biomarker Technology Market Overview by Asia-Pacific Region
Bioinformatics
Genomics
Molecular Imaging
Proteomics
Other Biomarker Discovery Technologies
2.1.3.5 Major Market Players
Astellas Pharma (Japan)
GVK Biosciences Private Ltd (India)
Human Metabolome Technologies Inc. (Japan)
Takeda Pharmaceutical Company Limited (Japan)

2.1.3.6 Asia-Pacific Market Overview by Country
Japan
China
India
Australia
Rest of Asia-Pacific

2.1.4 Rest of World
2.1.4.1 Market Overview by Biomarker Technology
2.1.4.2 Market Overview by Biomarker Therapeutic Area
2.1.4.3 Major Market Players
Ambrilia Biopharma Inc (Canada)
Compugen Ltd. (Israel)

3. GUIDE TO THE INDUSTRY
3.1 North America
3.1.1 Canada
3.1.2 United States
3.2 Europe
3.2.1 Belgium
3.2.2 Denmark
3.2.3 Finland
3.2.4 France
3.2.5 Germany
3.2.6 Iceland
3.2.7 Norway
3.2.8 Spain
3.2.9 Sweden
3.2.10 Switzerland
3.2.11 The Netherlands
3.2.12 United Kingdom
3.3 Asia-Pacific
3.3.1 Australia
3.3.2 China
3.3.3 India
3.3.4 Japan
3.4 Rest of World
3.4.1 Israel

4. ANNEXURE
4.1 Research methodology
4.2 The Questionnaire
4.3 Feedback

Charts & Graphs

GLOBAL MARKET PERSPECTIVE
Chart 1: Primary Areas of Guidance in Considering Molecular Imaging as a Cancer Biomarker
Chart 2: The Classes of Biomarkers as Defined by FDA Pharmacogenomics Guidelines
Chart 3: Global Biomarkers Market Analysis (2007-2015) in USD Million
Chart 4: Global Biomarkers Market Analysis (2007-2015) by Discovery Technology – Bioinformatics, Genomics, Molecular Imaging, Proteomics and Other in USD Million
Chart 5: Glance at 2007, 2010 and 2015 Global Biomarkers Market Share (%) by Discovery Technology – Bioinformatics, Genomics, Molecular Imaging, Proteomics and Other
Chart 6: Global Biomarkers Market Analysis (2007-2015) by Therapeutic Area – Cardiology, Neurology, Oncology and Other in USD Million
Chart 7: Glance at 2007, 2010 and 2015 Global Biomarkers Market Share (%) by Therapeutic Area – Cardiology, Neurology, Oncology and Other
Chart 8: Global Bioinformatics Market Analysis (2007-2015) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World in USD Million
Chart 9: Glance at 2007, 2010 and 2015 Global Bioinformatics Market Share (%) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World
Chart 10: Global Genomics Market Analysis (2007-2015) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World in USD Million
Chart 11: Glance at 2007, 2010 and 2015 Global Genomics Market Share (%) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World
Chart 12: Global Molecular Imaging Market Analysis (2007-2015) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World in USD Million
Chart 13: Glance at 2007, 2010 and 2015 Global Molecular Imaging Market Share (%) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World
Chart 14: Global Proteomics Market Analysis (2007-2015) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World in USD Million
Chart 15: Glance at 2007, 2010 and 2015 Global Proteomics Market Share (%) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World
Chart 16: Global Other Biomarker Discovery Technologies Market Analysis (2007-2015) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World in USD Million
Chart 17: Glance at 2007, 2010 and 2015 Global Other Biomarker Discovery Technologies Market Share (%) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World
Chart 18: Global Biomarkers Market Analysis (2007-2015) in Cardiology by Geographic Region – United States, Europe, Asia-Pacific and Rest of World in USD Million
Chart 19: Glance at 2007, 2010 and 2015 Global Cardiology Market Share (%) of Biomarkers by Geographic Region – United States, Europe, Asia-Pacific and Rest of World
Chart 20: Global Biomarkers Market Analysis (2007-2015) in Neurology by Geographic Region – United States, Europe, Asia-Pacific and Rest of World in USD Million
Chart 21: Glance at 2007, 2010 and 2015 Global Neurology Market Share (%) of Biomarkers by Geographic Region – United States, Europe, Asia-Pacific and Rest of World
Chart 22: Global Biomarkers Market Analysis (2007-2015) in Oncology by Geographic Region – United States, Europe, Asia-Pacific and Rest of World in USD Million
Chart 23: Glance at 2007, 2010 and 2015 Global Oncology Market Share (%) of Biomarkers by Geographic Region – United States, Europe, Asia-Pacific and Rest of World
Chart 24: Global Biomarkers Market Analysis (2007-2015) in Other Disease Areas by Geographic Region – United States, Europe, Asia-Pacific and Rest of World in USD Million
Chart 25: Glance at 2007, 2010 and 2015 Global Other Disease Areas Market Share (%) of Biomarkers by Geographic Region – United States, Europe, Asia-Pacific and Rest of World

REGIONAL MARKET PERSPECTIVE
Chart 26: The Projection of Largest Regions in terms of Market Growth for Biomarkers by Geography – Asia-Pacific, Europe, United States and Rest of World
Chart 27: Global Biomarkers Market Analysis (2007-2015) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World in USD Million
Chart 28: Glance at 2007, 2010 and 2015 Global Biomarkers Market Share (%) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World

The United States
Chart 29: United States Biomarkers Market Analysis (2007-2015) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other in USD Million
Chart 30: Glance at 2007, 2010 and 2015 United States Biomarkers Market Share (%) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other
Chart 31: United States Biomarkers Market Analysis (2007-2015) by Therapeutic Area – Cardiology, Neurology, Oncology and Other in USD Million
Chart 32: Glance at 2007, 2010 and 2015 United States Biomarkers Market Share (%) by Therapeutic Area – Cardiology, Neurology, Oncology and Other

EUROPE
Chart 33: European Biomarkers Market Analysis (2007-2015) by Geographic Region – Germany, United Kingdom, France, Italy, Spain, Sweden and Rest of Europe in USD Million
Chart 34: Glance at 2007, 2010 and 2015 European Biomarkers Market Share (%) by Geographic Region – Germany, United Kingdom, France, Italy, Spain, Sweden and Rest of Europe
Chart 35: European Biomarkers Market Analysis (2007-2015) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other in USD Million
Chart 36: Glance at 2007, 2010 and 2015 European Biomarkers Market Share (%) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other
Chart 37: European Biomarkers Market Analysis (2007-2015) by Therapeutic Area – Cardiology, Neurology, Oncology and Other in USD Million
Chart 38: Glance at 2007, 2010 and 2015 European Biomarkers Market Share (%) by Therapeutic Area – Cardiology, Neurology, Oncology and Other
Chart 39: European Bioinformatics Market Analysis (2007-2015) by Geographic Region – Germany, United Kingdom, France, Italy, Spain, Sweden and Rest of Europe in USD Million
Chart 40: Glance at 2007, 2010 and 2015 European Bioinformatics Market Share (%) by Geographic Region – Germany, United Kingdom, France, Italy, Spain, Sweden and Rest of Europe
Chart 41: European Genomics Market Analysis (2007-2015) by Geographic Region – Germany, United Kingdom, France, Italy, Spain, Sweden and Rest of Europe in USD Million
Chart 42: Glance at 2007, 2010 and 2015 European Genomics Market Share (%) by Geographic Region – Germany, United Kingdom, France, Italy, Spain, Sweden and Rest of Europe
Chart 43: European Imaging Market Analysis (2007-2015) by Geographic Region – Germany, United Kingdom, France, Italy, Spain, Sweden and Rest of Europe in USD Million
Chart 44: Glance at 2007, 2010 and 2015 European Imaging Market Share (%) by Geographic Region – Germany, United Kingdom, France, Italy, Spain, Sweden and Rest of Europe
Chart 45: European Proteomics Market Analysis (2007-2015) by Geographic Region – Germany, United Kingdom, France, Italy, Spain, Sweden and Rest of Europe in USD Million
Chart 46: Glance at 2007, 2010 and 2015 European Proteomics Market Share (%) by Geographic Region – Germany, United Kingdom, France, Italy, Spain, Sweden and Rest of Europe
Chart 47: European Other Biomarker Discovery Technologies Market Analysis (2007-2015) by Geographic Region – Germany, United Kingdom, France, Italy, Spain, Sweden and Rest of Europe in USD Million
Chart 48: Glance at 2007, 2010 and 2015 European Other Biomarker Discovery Technologies Market Share (%) by Geographic Region – Germany, United Kingdom, France, Italy, Spain, Sweden and Rest of Europe

Germany
Chart 49: German Biomarkers Market Analysis (2007-2015) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other in USD Million
Chart 50: Glance at 2007, 2010 and 2015 German Biomarkers Market Share (%) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other

The United Kingdom
Chart 51: United Kingdom Biomarkers Market Analysis (2007-2015) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other in USD Million
Chart 52: Glance at 2007, 2010 and 2015 United Kingdom Biomarkers Market Share (%) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other

French
Chart 53: French Biomarkers Market Analysis (2007-2015) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other in USD Million
Chart 54: Glance at 2007, 2010 and 2015 French Biomarkers Market Share (%) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other

Italian
Chart 55: Italian Biomarkers Market Analysis (2007-2015) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other in USD Million
Chart 56: Glance at 2007, 2010 and 2015 Italian Biomarkers Market Share (%) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other

Spanish
Chart 57: Spanish Biomarkers Market Analysis (2007-2015) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other in USD Million
Chart 58: Glance at 2007, 2010 and 2015 Spanish Biomarkers Market Share (%) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other

Sweden
Chart 59: Swedish Biomarkers Market Analysis (2007-2015) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other in USD Million
Chart 60: Glance at 2007, 2010 and 2015 Swedish Biomarkers Market Share (%) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other

Rest of Europe
Chart 61: Rest of Europe Biomarkers Market Analysis (2007-2015) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other in USD Million
Chart 62: Glance at 2007, 2010 and 2015 Rest of Europe Biomarkers Market Share (%) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other

ASIA-PACIFIC
Chart 63: Asia-Pacific Biomarkers Market Analysis (2007-2015) by Geographic Region – Japan, China, India, Australia and Rest of World in USD Million
Chart 64: Glance at 2007, 2010 and 2015 Asia-Pacific Biomarkers Market Share (%) by Geographic Region – Japan, China, India, Australia and Rest of World
Chart 65: Asia-Pacific Biomarkers Market Analysis (2007-2015) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other in USD Million
Chart 66: Glance at 2007, 2010 and 2015 Asia-Pacific Biomarkers Market Share (%) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other
Chart 67: Asia-Pacific Biomarkers Market Analysis (2007-2015) by Therapeutic Area – Cardiology, Neurology, Oncology and Other in USD Million
Chart 68: Glance at 2007, 2010 and 2015 Asia-Pacific Biomarkers Market Share (%) by Therapeutic Area – Cardiology, Neurology, Oncology and Other
Chart 69: Asia-Pacific Bioinformatics Market Analysis (2007-2015) by Geographic Region – Japan, China, India, Australia and Rest of World in USD Million
Chart 70: Glance at 2007, 2010 and 2015 Asia-Pacific Bioinformatics Market Share (%) by Geographic Region – Japan, China, India, Australia and Rest of World
Chart 71: Asia-Pacific Genomics Market Analysis (2007-2015) by Geographic Region – Japan, China, India, Australia and Rest of World in USD Million
Chart 72: Glance at 2007, 2010 and 2015 Asia-Pacific Genomics Market Share (%) by Geographic Region – Japan, China, India, Australia and Rest of World
Chart 73: Asia-Pacific Imaging Market Analysis (2007-2015) by Geographic Region – Japan, China, India, Australia and Rest of World in USD Million
Chart 74: Glance at 2007, 2010 and 2015 Asia-Pacific Imaging Market Share (%) by Geographic Region – Japan, China, India, Australia and Rest of World
Chart 75: Asia-Pacific Proteomics Market Analysis (2007-2015) by Geographic Region – Japan, China, India, Australia and Rest of World in USD Million
Chart 76: Glance at 2007, 2010 and 2015 Asia-Pacific Proteomics Market Share (%) by Geographic Region – Japan, China, India, Australia and Rest of World
Chart 77: Asia-Pacific Other Biomarker Discovery Technologies Market Analysis (2007-2015) by Geographic Region – Japan, China, India, Australia and Rest of World in USD Million
Chart 78: Glance at 2007, 2010 and 2015 Asia-Pacific Other Biomarker Discovery Technologies Market Share (%) by Geographic Region – Japan, China, India, Australia and Rest of World

Japan
Chart 79: Japanese Biomarkers Market Analysis (2007-2015) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other in USD Million
Chart 80: Glance at 2007, 2010 and 2015 Japanese Biomarkers Market Share (%) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other

China
Chart 81: Chinese Biomarkers Market Analysis (2007-2015) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other in USD Million
Chart 82: Glance at 2007, 2010 and 2015 Chinese Biomarkers Market Share (%) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other

India
Chart 83: Indian Biomarkers Market Analysis (2007-2015) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other in USD Million
Chart 84: Glance at 2007, 2010 and 2015 Indian Biomarkers Market Share (%) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other

Australia
Chart 85: Australian Biomarkers Market Analysis (2007-2015) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other in USD Million
Chart 86: Glance at 2007, 2010 and 2015 Australian Biomarkers Market Share (%) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other

Rest of Asia-Pacific
Chart 87: Rest of Asia-Pacific Biomarkers Market Analysis (2007-2015) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other in USD Million
Chart 88: Glance at 2007, 2010 and 2015 Rest of Asia-Pacific Biomarkers Market Share (%) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other

REST OF WORLD
Chart 89: Rest of World Biomarkers Market Analysis (2007-2015) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other in USD Million
Chart 90: Glance at 2007, 2010 and 2015 Rest of World Biomarkers Market Share (%) by Discovery Technology – Bioinformatics, Genomics, Imaging, Proteomics and Other
Chart 91: Rest of World Biomarkers Market Analysis (2007-2015) by Therapeutic Area – Cardiology, Neurology, Oncology and Other in USD Million
Chart 92: Glance at 2007, 2010 and 2015 Rest of World Biomarkers Market Share (%) by Therapeutic Area – Cardiology, Neurology, Oncology and Other

Abbott Laboratories
ACE BioSciences A/S
Affibody AB
Affymetrix, Inc.
Agilent Technologies
Amgen
Applied NeuroSolutions
AstraZeneca plc
AVIVA Biosciences Corporation
Bayer AG
Beckman Coulter, Inc.
Becton, Dickinson and Company
BG Medicine, Inc.
Biacore International AB
Biocartis
Biomarker Pharmaceuticals, Inc.
Bio-Rad Laboratories
Boehringer Ingelheim
Bristol-Myers Squibb Company
Celera Corporation
Charles River Laboratories International, Inc.
Clarient, Inc.
Compugen Ltd.
Dako A/S
deCODE Genetics
Eli Lilly and Company
GE Healthcare
Gene Logic, Inc.
Genedata AG
GeneGo
Genentech, Inc.
Geron Corporation
GlaxoSmithKline
GVK Biosciences Private Ltd
HistoRx, Inc.
Merck & Co., Inc.
Millennium Pharmaceuticals, Inc.
Millipore Corporation
Monogram Biosciences, Inc.
Myriad Genetics, Inc.
Novartis AG
OSI Pharmaceuticals
PerkinElmer, Inc.
Pfizer, Inc.
Philips Healthcare
Roche Diagnostics Corporation
Sanofi-Aventis
Shimadzu Scientific Instruments, Inc.
Siemens Healthcare Diagnostics Inc.
Sigma-Aldrich Corporation
Takeda Pharmaceutical Company Limited
Thermo Fisher Scientific, Inc.